Little information is available on the environmental occurrence and ecotoxicological effects 33 of pharmaceutical gestagens released in the aquatic environment. Since eighteen different 34 gestagens were found to be used in France, preliminary exposure and hazard assessment were 35 done. Predicted environmental concentrations (PECs) suggest that if parent gestagens are 36 expected to be found in the ng.l −1 range, some active metabolites could be present at higher 37 concentrations, although limited data on metabolism and environmental fate limit the 38 relevance of PECs. The biological effects are not expected to be restricted to progestagenic 39 activity. Both anti-androgenic activity (mainly for cyproterone acetate, chlormadinone acetate 40 and their metabolites) and estrogenic activity (mainly for reduced metabolites of 41 levonorgestrel and norethisterone) should also occur. 
2.Material and methods: 151 152
This paper has two main goals: i) to review the ecotoxicological and pharmacological 153 knowledge on progestogens used in human medicine to provide an overview of the biological 154 effects of these molecules and ii) to assess the exposure to the aquatic environment by 155 calculating predicted environmental concentrations (PECs) and to provide a preliminary 156 characterization of the risk for gestagens. 157
To do so, the scientific literature was reviewed, as well as the following databases and books: 158 the Banque Claude Bernard (BCB), a complete, free French databank on human 159 pharmaceuticals (http://www.resip.fr), the BIAM database (www.biam2.org), the drugs.com 160 drug database (www.drugs.com), the Micromedex Drugdex® databank (from Thomson 161 Micromedex, available at www.micromedex.com/products/drugdex), the Martindale 162 compendium's Complete Drug Reference (Martindale 2002) , Les progestatifs (Rozenbaum, 163 2001) and the Goodman and Gilman's The Pharmacological Basis of Therapeutics (Hardman 164 et al. 1996) . Special attention was paid to the metabolism and active metabolites of gestagens. 165
As highlighted in previous studies on pharmaceuticals, metabolism is one of the most 166 important processes that can reduce the quantities of pharmaceuticals reaching the aquatic 167 environment. Moreover, human metabolism can give rise to metabolites ( acts primarily on a double-bond of ring A then on the ketone function of carbon 3. These 201 structural modifications lead to metabolites that can be pharmacologically active but whose 202 activity differs from the parent compounds. The parent compound and metabolites can 203 subsequently be sulfo-and glucuroconjugated prior to excretion (Stanczyk, 2003; 204 Rozenbaum, 2001 ). Information on gestagen metabolites is summarized in Table 3 (Table 5 ). Three very recent 239 studies also report the occurrence of gestagens in different environmental samples (Table 5) ng.l −1 . This metabolite is reported to be inactive. Moreover, it has undoubtedly been present in 278 the environment for decades, and there is no evidence that any biological effect is related to it. 279
However, considering the rates of its release into the environment through WWTPs, which 280
should have considerably increased with the use of P4 in HRT, concerns are being raised and 281 studies should investigate the fate and toxicity of this molecule. 282
Other metabolites with estrogenic activity could be found in surface waters at higher levels 283 than parent compounds. Following an oral administration of NET (Stanczyk and Roy, 1990) , 284 there was five times more 3α-5β-tetrahydro-NET (free and conjugated) than NET (free and 285 conjugated) in urine. The same study showed that total urinary amounts of 3α-5β-tetrahydro-286 LNG (free and conjugated) were 15 times higher than total amounts of LNG. Although there 287 is a need for more studies, especially to determine WWTP removal rates of these molecules, 288
these results indicate that wastewater effluent levels for 3α-5β-tetrahydro-NET and 3α-5β-289 tetrahydro-LNG could be up to 45 ng.l −1 and 240 ng.l −1 , respectively (by taking into account 290 maximum values for NET and LNG reported in Table 5 and assuming comparable removal  291 rates for parent compounds and metabolites). Therefore, there is evidence that most relevant 292 compounds according to the environmental exposure and biological activity have not been 293 targeted yet. 294 However, except for CPA, which was assessed for its anti-androgenic properties, no 338 ecotoxicological data in fish were found. 339
Very few data are available on the ecotoxicity of gestagens on aquatic invertebrates. A very 340 recent study, assessing the effects of estradiol, EE2 and MPA on the cladoceran Ceriodaphnia 341 dubia, showed no effect on reproduction at concentrations ranging from 5 µg.l −1 to 5 mg.l detect hormonal activities in water samples. These authors showed that there were multiple 386 hormonal activities in effluent samples. Progestagenic activity was found in only half of the 387 samples, whereas estrogenic activity and glucocorticoid activity was found in all the samples. 388
Higher progestagenic activity was found in an industrial effluent sample than in municipal 389 effluents, suggesting that the contribution of gestagens used by humans to the aquatic 390 contamination is not the major one. No activity was found in paper mill effluent, whereas a 391 previous study (Jenkins et al., 2003) detected natural progesterone in sediment and surface 392 waters exposed to paper mill effluent in concentrations 100 times higher than at a reference 393 site. No progestagenic activity was found in hospital effluents, perhaps because most of the 394 progestagen consumption is used for hormone replacement therapy or contraceptives and is 395 therefore used outside hospitals. Nevertheless, P4 has been found in hospital WWTPs 396 clearly assess the estrogenic activity of 3α-5β-tetrahydroderivatives. Nevertheless, since NES 427 and GES are reported to have estrogenic activity (Table 1) , there is strong evidence that their 428 metabolites display this activity. 429
As discussed above, concentrations of these metabolites entering the aquatic environment 430 could be higher than those of parent compounds; therefore, there is a potential risk of 431 estrogenic activity. They have a similar mode of action to estrogen: consequently, 432 tetrahydroderivatives and to a lesser extent, dihydroderivative metabolites from progestins 433 Occurrence studies should also be conducted on DHG, which is the third-ranked molecule in 478 terms of consumption amounts (Table 5 ). As DHG is mainly metabolized in the active DHD, 479 occurrence studies should also investigate this last molecule. 480
Tetrahydro-metabolites of LNG, GSD and NET, and the metabolites of TBL, are likely to 481 exert an estrogenic activity. Since GSD is used in low amounts (Table 5) , concentrations of 482 this compound and its metabolites entering the environment are expected to be negligible. On 483 the contrary, occurrence and ecotoxicological studies should focus on 3α,5β tetrahydro-484 metabolites of LNG and NET and on 3α hydroxylated metabolite of TBL.because they display a significant anti-androgenic activity. 487
Given that pregnanediol could be excreted in significant amounts, it should be tested for 488 ecotoxicity and occurrence. 
